Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys.
Taylor
J R
JR
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510.
Lawrence
M S
MS
Redmond
D E
DE
Elsworth
J D
JD
Roth
R H
RH
Nichols
D E
DE
Mailman
R B
RB
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D002522:Chlorocebus aethiops; D004298:Dopamine / Q000502:physiology; D015259:Dopamine Agents / Q000494:pharmacology*; D008297:Male; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy*; D010617:Phenanthridines / Q000494:pharmacology*
D015259:Dopamine Agents; D010617:Phenanthridines; C061532:dihydrexidine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine